Coronary vessel formation in development and disease: mechanisms and insights for therapy
- PMID: 32587347
- DOI: 10.1038/s41569-020-0400-1
Coronary vessel formation in development and disease: mechanisms and insights for therapy
Abstract
The formation of new blood vessels after myocardial infarction (MI) is essential for the survival of existing and regenerated cardiac tissue. However, the extent of endogenous revascularization after MI is insufficient, and MI can often result in ventricular remodelling, progression to heart failure and premature death. The neutral results of numerous clinical trials that have evaluated the efficacy of angiogenic therapy to revascularize the infarcted heart reflect our poor understanding of the processes required to form a functional coronary vasculature. In this Review, we describe the latest advances in our understanding of the processes involved in coronary vessel formation, with mechanistic insights taken from developmental studies. Coronary vessels originate from multiple cellular sources during development and form through a number of distinct and carefully orchestrated processes. The ectopic reactivation of developmental programmes has been proposed as a new paradigm for regenerative medicine, therefore, a complete understanding of these processes is crucial. Furthermore, knowledge of how these processes differ between the embryonic and adult heart, and how they might be more closely recapitulated after injury are critical for our understanding of regenerative biology, and might facilitate the identification of tractable molecular targets to therapeutically promote neovascularization and regeneration of the infarcted heart.
Similar articles
-
Recapitulation of developmental mechanisms to revascularize the ischemic heart.JCI Insight. 2017 Nov 16;2(22):e96800. doi: 10.1172/jci.insight.96800. eCollection 2017 Nov 16. JCI Insight. 2017. PMID: 29202457 Free PMC article.
-
Coronary vessel formation in development and regeneration: origins and mechanisms.J Mol Cell Cardiol. 2022 Jun;167:67-82. doi: 10.1016/j.yjmcc.2022.03.009. Epub 2022 Mar 27. J Mol Cell Cardiol. 2022. PMID: 35354073 Review.
-
The Development and Regeneration of Coronary Arteries.Curr Cardiol Rep. 2018 May 25;20(7):54. doi: 10.1007/s11886-018-0999-2. Curr Cardiol Rep. 2018. PMID: 29802591 Review.
-
Prospects for improving neovascularization of the ischemic heart: Lessons from development.Microcirculation. 2017 Jan;24(1). doi: 10.1111/micc.12335. Microcirculation. 2017. PMID: 27859990 Review.
-
Angiogenesis after acute myocardial infarction.Cardiovasc Res. 2021 Apr 23;117(5):1257-1273. doi: 10.1093/cvr/cvaa287. Cardiovasc Res. 2021. PMID: 33063086 Review.
Cited by
-
Alteration of endothelial permeability ensures cardiomyocyte survival from ischemic insult in the subendocardium of the heart.Exp Biol Med (Maywood). 2023 Aug;248(16):1364-1372. doi: 10.1177/15353702231194344. Epub 2023 Oct 3. Exp Biol Med (Maywood). 2023. PMID: 37786370
-
Coronary artery established through amniote evolution.Elife. 2023 Aug 22;12:e83005. doi: 10.7554/eLife.83005. Elife. 2023. PMID: 37605519 Free PMC article.
-
Animal models to study cardiac regeneration.Nat Rev Cardiol. 2024 Feb;21(2):89-105. doi: 10.1038/s41569-023-00914-x. Epub 2023 Aug 14. Nat Rev Cardiol. 2024. PMID: 37580429 Review.
-
Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease.Front Cardiovasc Med. 2023 Mar 14;10:1104223. doi: 10.3389/fcvm.2023.1104223. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36998978 Free PMC article.
-
Endothelial deletion of Wt1 disrupts coronary angiogenesis and myocardium development.Development. 2023 Mar 15;150(6):dev201147. doi: 10.1242/dev.201147. Epub 2023 Mar 27. Development. 2023. PMID: 36852644 Free PMC article.
References
-
- Padro, T. et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’. Cardiovasc. Res. 116, 741–755 (2020).
-
- Seiler, C., Stoller, M., Pitt, B. & Meier, P. The human coronary collateral circulation: development and clinical importance. Eur. Heart J. 34, 2674–2682 (2013).
-
- Reffelmann, T. & Kloner, R. A. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic. Res. Cardiol. 101, 359–372 (2006).
-
- Regenfus, M. et al. Six-year prognostic value of microvascular obstruction after reperfused ST-elevation myocardial infarction as assessed by contrast-enhanced cardiovascular magnetic resonance. Am. J. Cardiol. 116, 1022–1027 (2015).
-
- Giacca, M. & Zacchigna, S. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther. 19, 622–629 (2012).
Publication types
MeSH terms
Grants and funding
- PG/18/62/33967/BHF_/British Heart Foundation/United Kingdom
- PG/15/112/31940/BHF_/British Heart Foundation/United Kingdom
- FS/17/35/32929/BHF_/British Heart Foundation/United Kingdom
- FS/19/32/34376/BHF_/British Heart Foundation/United Kingdom
- PG/16/34/32135/BHF_/British Heart Foundation/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
